Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 47,226 | 41,271 | 37,650 | 29,886 | 28,917 |
| Operating Income | -47,226 | -41,271 | -37,650 | -29,886 | -28,917 |
| Other Income | 43 | -114 | -84 | -626 | 680 |
| Pre-tax Income | -47,183 | -41,385 | -37,734 | -30,512 | -28,237 |
| Income Tax | -12 | N/A | -31 | -41 | -79 |
| Net Income Continuous | -47,171 | -41,385 | -37,703 | -30,471 | -28,158 |
| Net Income | $-47,171 | $-41,385 | $-37,703 | $-30,471 | $-28,158 |
| EPS Basic Total Ops | -0.41 | -0.36 | -0.35 | -0.31 | -0.27 |
| EPS Basic Continuous Ops | -0.41 | -0.36 | -0.35 | -0.31 | -0.28 |
| EPS Diluted Total Ops | -0.41 | -0.36 | -0.35 | -0.31 | -0.27 |
| EPS Diluted Continuous Ops | -0.41 | -0.36 | -0.35 | -0.31 | -0.28 |
| EBITDA(a) | $-47,226 | $-41,271 | $-37,622 | $-29,860 | $-28,895 |